Prestige Consumer Healthcare Inc. buy BMO Capital Markets
Start price
15.11.23
/
50%
€53.50
Target price
15.11.24
€107.78
Performance (%)
42.99%
End price
16.11.24
€76.50
Summary
This prediction ended on 16.11.24 with a price of €76.50. With a performance of 42.99% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 1.905% | 1.905% | -28.667% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% |
Comments by BMO_Capital_Markets for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten